ea0090ep889 | Pituitary and Neuroendocrinology | ECE2023
Joel Rudy Ekoundzola
, Rafi Sana
, El Mghari Ghizlane
, El Ansari Nawal
Introduction: Medical treatment of acromegaly with somatostatin analogues (SAs) has been used for a long time and is a well-established treatment in cases where surgery, which is the first-line treatment, is impossible or inadequate. We report a case of acromegaly under control after initiation of Lanreotide.Observation: Patient aged 59 years, referred for acromegaloid dysmorphic syndrome initially with tumor syndrome with IGF1 workup at 729 ng/mL (norma...